Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years
نویسندگان
چکیده
منابع مشابه
Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years.
BACKGROUND Dialysis-related amyloidosis is one of the chronic the complications of haemodialysis. We conducted an investigation of dialysis-associated amyloidosis in extremely long-term survivors. METHODS Twenty-one patients on haemodialysis for more than 30 years ('30+' group) and 13 patients on haemodialysis for 20-30 years ('20-30' group) at Sangenjaya Hospital were enrolled in this study....
متن کاملCharacteristics of body composition and nutritional status in patients receiving hemodialysis therapy for more than 30 years.
BACKGROUND/AIMS We investigated the body composition and nutritional status of extremely long-term (more than 30 years) hemodialysis patients. METHODS Eighty outpatients receiving maintenance hemodialysis (including 18 for more than 30 years) were enrolled. We classified the patients according to the duration of hemodialysis therapy (less than 10 years, 10-20 years, 20-30 years, or over 30 ye...
متن کاملPatients surviving more than 10 years on haemodialysis. The natural history of the complications of treatment.
BACKGROUND The purpose of this survey was to describe the natural history of complications in 52 long-surviving haemodialysis patients to obtain a clearer picture of the impact these patients have on the dialysis population. This is important as they are often no longer suitable for transplantation and therefore are destined to remain on dialysis for the rest of their lives. METHODS The patie...
متن کاملTranscatheter Arterial Chemoembolization: History for More than 30 Years
Transcatheter arterial chemoembolization (TACE) is a minimally invasive technique to treat liver tumors, particularly hepatocellular carcinoma (HCC). TACE was used in early times to treat liver tumor patients with emergencies caused by symptomatic humoral hypercalcemia and develops gradually from the procedures of diagnostic angiography and transcatheter injection of agents and is in particular...
متن کاملLong-term survival (10 years or more) in 30 patients with primary amyloidosis.
The median survival in primary systemic (AL) amyloidosis is less than 18 months. No published series of patients with AL amyloidosis have reported survival of more than 10 years. The records of all Mayo Clinic patients with a diagnosis of AL amyloidosis between January 1, 1966 and March 1, 1987 were reviewed. Patients with secondary amyloidosis, familial amyloidosis, senile systemic amyloidosis...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2008
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gfn706